An Introduction to Bioanalysis of Biopharmaceuticals

An Introduction to Bioanalysis of Biopharmaceuticals

171,19 €*

in Vorbereitung

The book provides a comprehensive review of the fundamental and practical aspects of bioanalytical support and the integral role it plays in the development of safe and efficacious biopharmaceutical drugs with speed and cost-effectiveness. The book focuses on a broad range of conventional and emerging biopharmaceutical modalities including monoclonal antibody-based therapeutics, gene therapy, cell therapy, peptides and oligonucleotides.


The book starts with an introductory overview of bioanalysis showcasing the integral role it plays in understanding the drug disposition (pharmacokinetics/pharmacodynamics and immunogenicity) and the progression of bioanalytical strategy as the drug progresses through discovery and development stages of the program, taking into consideration the continually evolving regulatory landscape.


The book further diversifies into individual biopharmaceutical modalities - monoclonal antibodies, antibody-drug conjugates, bispecifics, Fc-fusion proteins, gene therapies, cell therapies, peptides and oligonucleotides. The individual chapters focus on modality-specific bioanalytical assay strategies, critical reagents, assay formats, analytical platforms, associated bioanalytical challenges and mitigation strategies, industry best practices, and the latest understanding of regulatory guidance as applicable to the fast-growing biopharmaceutical landscape.

Bioanalytical Support in Drug Discovery and Development,- Monoclonal Antibodies
Antibody Drug Conjugates (ADCS)
Bispecifics and Fusion Proteins
Emerging Modalities-Part A- (Gene Therapy and Cell Therapy)
Emerging Modalities Part B (Peptides, Oligonucleotide Based Therapy, Vaccines. 
ISBN 978-3-030-99998-8
Artikelnummer 9783030999988
Medientyp Buch
Auflage 1st ed. 2022
Copyrightjahr 2023
Verlag Springer, Berlin
Umfang IX, 160 Seiten
Abbildungen IX, 160 p. 25 illus., 19 illus. in color.
Sprache Englisch